Sinopharm Group Co Ltd operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sinopharm Group Co Ltd with three other
drug stores in Asia:
Alfresa Holdings Corporation
sales of 2.42 trillion Japanese Yen [US$23.32 billion]
of which 91%
was Wholesale Business of Pharmaceuticals fo),
Medipal Holdings Corporation
(2.87 trillion Japanese Yen [US$27.67 billion]
of which 71%
was Pharmaceuticals And Other Products Whole), and
Suzuken Co., Ltd.
based in Japan
(1.97 trillion Japanese Yen [US$18.97 billion]
of which 93%
was Pharmaceutical Wholesale Business).
During the year ended December of 2015, sales at
Sinopharm Group Co Ltd were 227.07 billion Chinese Renmimbi (US$33.69 billion).
increase of 13.5%
versus 2014, when the company's sales were 200.13 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Sinopharm Group Co Ltd
(and since 2010, sales have increased a total of 228%).
Sales of Retail Pharmacy Operations saw an increase
that was more than double the company's growth rate: sales were up
47.7% in 2015, from
5.90 billion Chinese Renmimbi to 8.71 billion Chinese Renmimbi.